2 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 35604681 | CUB domain containing protein 1 (CDCP1) is a target for radioligand therapy in castration resistant prostate cancer including PSMA null disease. | 2022 May 23 | 1 |
| 2 | 32250342 | CDCP1 overexpression drives prostate cancer progression and can be targeted in vivo. | 2020 May 1 | 2 |